WHO: Trials Show New Ebola Vaccine is 'Highly Effective'

On March 23, 2015, Medecins Sans Frontieres (Doctors Without Borders) together with the World Health Organization started a clinical trial in Guinea to test the safety, efficacy and capacity substance to provoke an immune response of the anti-Ebola vaccine rVSV-EBOV.

cnn.com - by Laura Smith-Spark - July 31, 2015

(CNN) A newly developed vaccine against the deadly Ebola virus is "highly effective" and could help prevent its spread in the current and future outbreaks, the World Health Organization said Friday.

Trials of the single-dose VSV-EBOV vaccine began in March in Guinea -- one of three West African nations at the center of the outbreak -- and have shown such promise that this week it was decided to extend immediate vaccination to "all people at risk" after close contact with an infected person, a WHO news release said.

"This is an extremely promising development," said Dr. Margaret Chan, the body's director general.

(READ COMPLETE ARTICLE)

CLICK HERE - The Lancet - Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

CLICK HERE - The Lancet - An Ebola vaccine: first results and promising opportunities

CLICK HERE - The Lancet - Ebola Resource Center

(ALSO SEE RELATED ARTICLE HERE)